{"count":220324,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1328","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1326","results":[{"created":"2021-05-07T12:55:52.099063+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.110","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: znfx1 has been classified as Green List (High Evidence).","entity_name":"ZNFX1","entity_type":"gene"},{"created":"2021-05-07T12:55:18.610321+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"gene: ZNFX1 was added\ngene: ZNFX1 was added to Systemic Autoinflammatory Disease_Periodic Fever. Sources: Literature\nMode of inheritance for gene: ZNFX1 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: ZNFX1 were set to 33872655\nPhenotypes for gene: ZNFX1 were set to Multisystem inflammation; susceptibility to viral infections\nReview for gene: ZNFX1 was set to GREEN\nAdded comment: 15 individuals from 8 families reported. \nSources: Literature","entity_name":"ZNFX1","entity_type":"gene"},{"created":"2021-05-07T12:52:51.290842+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.102","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: UPB1 as ready","entity_name":"UPB1","entity_type":"gene"},{"created":"2021-05-07T12:52:51.281130+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.102","user_name":"Seb Lunke","item_type":"entity","text":"Gene: upb1 has been classified as Red List (Low Evidence).","entity_name":"UPB1","entity_type":"gene"},{"created":"2021-05-07T12:52:47.427373+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.102","user_name":"Seb Lunke","item_type":"entity","text":"Phenotypes for gene: UPB1 were changed from Beta-ureidopropionase deficiency, 613161 (3) to Beta-ureidopropionase deficiency, MIM #613161","entity_name":"UPB1","entity_type":"gene"},{"created":"2021-05-07T12:52:35.564114+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.101","user_name":"Seb Lunke","item_type":"entity","text":"Publications for gene: UPB1 were set to ","entity_name":"UPB1","entity_type":"gene"},{"created":"2021-05-07T12:52:24.247045+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.100","user_name":"Seb Lunke","item_type":"entity","text":"Classified gene: UPB1 as Red List (low evidence)","entity_name":"UPB1","entity_type":"gene"},{"created":"2021-05-07T12:52:24.234887+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.100","user_name":"Seb Lunke","item_type":"entity","text":"Gene: upb1 has been classified as Red List (Low Evidence).","entity_name":"UPB1","entity_type":"gene"},{"created":"2021-05-07T12:52:17.758007+10:00","panel_name":"Deafness_IsolatedAndComplex","panel_id":209,"panel_version":"1.71","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: STXBP3 as ready","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:52:17.749427+10:00","panel_name":"Deafness_IsolatedAndComplex","panel_id":209,"panel_version":"1.71","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: stxbp3 has been classified as Green List (High Evidence).","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:52:13.210871+10:00","panel_name":"Deafness_IsolatedAndComplex","panel_id":209,"panel_version":"1.71","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: STXBP3 as Green List (high evidence)","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:52:13.202279+10:00","panel_name":"Deafness_IsolatedAndComplex","panel_id":209,"panel_version":"1.71","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: stxbp3 has been classified as Green List (High Evidence).","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:51:48.218644+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.99","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: POLA1 as ready","entity_name":"POLA1","entity_type":"gene"},{"created":"2021-05-07T12:51:48.208490+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.99","user_name":"Seb Lunke","item_type":"entity","text":"Gene: pola1 has been classified as Amber List (Moderate Evidence).","entity_name":"POLA1","entity_type":"gene"},{"created":"2021-05-07T12:51:44.406970+10:00","panel_name":"Deafness_IsolatedAndComplex","panel_id":209,"panel_version":"1.70","user_name":"Zornitza Stark","item_type":"entity","text":"gene: STXBP3 was added\ngene: STXBP3 was added to Deafness_IsolatedAndComplex. Sources: Literature\nMode of inheritance for gene: STXBP3 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: STXBP3 were set to 33891011\nPhenotypes for gene: STXBP3 were set to Very Early Onset Inflammatory Bowel Disease; Bilateral Sensorineural Hearing Loss; Immune Dysregulation\nReview for gene: STXBP3 was set to GREEN\nAdded comment: 10 individuals from 5 families reported. \nSources: Literature","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:51:32.864529+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.99","user_name":"Seb Lunke","item_type":"entity","text":"Phenotypes for gene: POLA1 were changed from Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3), X-linked recessive to Pigmentary disorder, reticulate, with systemic manifestations, X-linked, MIM#301220; Van Esch-O'Driscoll syndrome, MIM #301030","entity_name":"POLA1","entity_type":"gene"},{"created":"2021-05-07T12:51:10.383532+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.98","user_name":"Seb Lunke","item_type":"entity","text":"Classified gene: POLA1 as Amber List (moderate evidence)","entity_name":"POLA1","entity_type":"gene"},{"created":"2021-05-07T12:51:10.369766+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.98","user_name":"Seb Lunke","item_type":"entity","text":"Gene: pola1 has been classified as Amber List (Moderate Evidence).","entity_name":"POLA1","entity_type":"gene"},{"created":"2021-05-07T12:51:10.080106+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7536","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: STXBP3 as ready","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:51:10.068613+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7536","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: stxbp3 has been classified as Green List (High Evidence).","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:50:50.932346+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7536","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: STXBP3 as Green List (high evidence)","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:50:50.923402+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7536","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: stxbp3 has been classified as Green List (High Evidence).","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:50:44.985361+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.97","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: TBX22 as ready","entity_name":"TBX22","entity_type":"gene"},{"created":"2021-05-07T12:50:44.975379+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.97","user_name":"Seb Lunke","item_type":"entity","text":"Gene: tbx22 has been classified as Red List (Low Evidence).","entity_name":"TBX22","entity_type":"gene"},{"created":"2021-05-07T12:50:38.062520+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.97","user_name":"Seb Lunke","item_type":"entity","text":"Classified gene: TBX22 as Red List (low evidence)","entity_name":"TBX22","entity_type":"gene"},{"created":"2021-05-07T12:50:38.050374+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.97","user_name":"Seb Lunke","item_type":"entity","text":"Gene: tbx22 has been classified as Red List (Low Evidence).","entity_name":"TBX22","entity_type":"gene"},{"created":"2021-05-07T12:50:16.199017+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7535","user_name":"Zornitza Stark","item_type":"entity","text":"gene: STXBP3 was added\ngene: STXBP3 was added to Mendeliome. Sources: Literature\nMode of inheritance for gene: STXBP3 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: STXBP3 were set to 33891011\nPhenotypes for gene: STXBP3 were set to Very Early Onset Inflammatory Bowel Disease; Bilateral Sensorineural Hearing Loss; Immune Dysregulation\nReview for gene: STXBP3 was set to GREEN\nAdded comment: 10 individuals from 5 families reported. \nSources: Literature","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:50:15.380111+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.96","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: MBTPS1 as ready","entity_name":"MBTPS1","entity_type":"gene"},{"created":"2021-05-07T12:50:15.343660+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.96","user_name":"Seb Lunke","item_type":"entity","text":"Gene: mbtps1 has been classified as Amber List (Moderate Evidence).","entity_name":"MBTPS1","entity_type":"gene"},{"created":"2021-05-07T12:50:04.017463+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.96","user_name":"Seb Lunke","item_type":"entity","text":"Classified gene: MBTPS1 as Amber List (moderate evidence)","entity_name":"MBTPS1","entity_type":"gene"},{"created":"2021-05-07T12:50:04.011569+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.96","user_name":"Seb Lunke","item_type":"entity","text":"Added comment: Comment on list classification: Not quite enough for MM","entity_name":"MBTPS1","entity_type":"gene"},{"created":"2021-05-07T12:50:03.966159+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.96","user_name":"Seb Lunke","item_type":"entity","text":"Gene: mbtps1 has been classified as Amber List (Moderate Evidence).","entity_name":"MBTPS1","entity_type":"gene"},{"created":"2021-05-07T12:50:01.428031+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.108","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: STXBP3 as ready","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:50:01.417687+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.108","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: stxbp3 has been classified as Green List (High Evidence).","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:49:37.512072+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.108","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: STXBP3 as Green List (high evidence)","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:49:37.503167+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.108","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: stxbp3 has been classified as Green List (High Evidence).","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:49:16.959846+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.95","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: COL2A1 as ready","entity_name":"COL2A1","entity_type":"gene"},{"created":"2021-05-07T12:49:16.921197+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.95","user_name":"Seb Lunke","item_type":"entity","text":"Gene: col2a1 has been classified as Amber List (Moderate Evidence).","entity_name":"COL2A1","entity_type":"gene"},{"created":"2021-05-07T12:49:12.768957+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.95","user_name":"Seb Lunke","item_type":"entity","text":"Phenotypes for gene: COL2A1 were changed from Otospondylomegaepiphyseal dysplasia, 215150 (3) to Spondyloperipheral dysplasia, MIM #271700","entity_name":"COL2A1","entity_type":"gene"},{"created":"2021-05-07T12:48:56.200034+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.94","user_name":"Seb Lunke","item_type":"entity","text":"Publications for gene: COL2A1 were set to ","entity_name":"COL2A1","entity_type":"gene"},{"created":"2021-05-07T12:48:46.153507+10:00","panel_name":"Systemic Autoinflammatory Disease_Periodic Fever","panel_id":238,"panel_version":"0.107","user_name":"Zornitza Stark","item_type":"entity","text":"gene: STXBP3 was added\ngene: STXBP3 was added to Systemic Autoinflammatory Disease_Periodic Fever. Sources: Literature\nMode of inheritance for gene: STXBP3 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: STXBP3 were set to 33891011\nPhenotypes for gene: STXBP3 were set to Very Early Onset Inflammatory Bowel Disease; Bilateral Sensorineural Hearing Loss; Immune Dysregulation\nReview for gene: STXBP3 was set to GREEN\nAdded comment: 10 individuals from 5 families reported. \nSources: Literature","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:48:43.497213+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.93","user_name":"Seb Lunke","item_type":"entity","text":"Mode of inheritance for gene: COL2A1 was changed from BIALLELIC, autosomal or pseudoautosomal to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"COL2A1","entity_type":"gene"},{"created":"2021-05-07T12:48:23.664518+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.92","user_name":"Seb Lunke","item_type":"entity","text":"Classified gene: COL2A1 as Amber List (moderate evidence)","entity_name":"COL2A1","entity_type":"gene"},{"created":"2021-05-07T12:48:23.653759+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.92","user_name":"Seb Lunke","item_type":"entity","text":"Gene: col2a1 has been classified as Amber List (Moderate Evidence).","entity_name":"COL2A1","entity_type":"gene"},{"created":"2021-05-07T12:47:52.396889+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.57","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: STXBP3 as Green List (high evidence)","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:47:52.387761+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.57","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: stxbp3 has been classified as Green List (High Evidence).","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:47:37.492183+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.91","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: NYX as ready","entity_name":"NYX","entity_type":"gene"},{"created":"2021-05-07T12:47:37.475883+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.91","user_name":"Seb Lunke","item_type":"entity","text":"Gene: nyx has been classified as Green List (High Evidence).","entity_name":"NYX","entity_type":"gene"},{"created":"2021-05-07T12:47:32.173219+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: STXBP3 as Green List (high evidence)","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:47:32.160910+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: stxbp3 has been classified as Green List (High Evidence).","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:47:30.893955+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.55","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: STXBP3 as ready","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:47:30.881212+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.55","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: stxbp3 has been classified as Red List (Low Evidence).","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:47:29.836551+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.91","user_name":"Seb Lunke","item_type":"entity","text":"Phenotypes for gene: NYX were changed from Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3) to Night blindness, congenital stationary (complete), 1A, X-linked, MIM #310500","entity_name":"NYX","entity_type":"gene"},{"created":"2021-05-07T12:46:52.058406+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.90","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: CLCN4 as ready","entity_name":"CLCN4","entity_type":"gene"},{"created":"2021-05-07T12:46:52.040543+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.90","user_name":"Seb Lunke","item_type":"entity","text":"Gene: clcn4 has been classified as Green List (High Evidence).","entity_name":"CLCN4","entity_type":"gene"},{"created":"2021-05-07T12:46:47.762976+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.90","user_name":"Seb Lunke","item_type":"entity","text":"Phenotypes for gene: CLCN4 were changed from Mental retardation, X-linked 49/15, 300114 (3), X-linked recessive to Raynaud-Claes syndrome, MIM #300114","entity_name":"CLCN4","entity_type":"gene"},{"created":"2021-05-07T12:46:46.764088+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.55","user_name":"Zornitza Stark","item_type":"entity","text":"gene: STXBP3 was added\ngene: STXBP3 was added to Inflammatory bowel disease. Sources: Literature\nMode of inheritance for gene: STXBP3 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: STXBP3 were set to 33891011\nPhenotypes for gene: STXBP3 were set to Very Early Onset Inflammatory Bowel Disease; Bilateral Sensorineural Hearing Loss; Immune Dysregulation\nReview for gene: STXBP3 was set to GREEN\nAdded comment: 10 individuals from 5 families reported. \nSources: Literature","entity_name":"STXBP3","entity_type":"gene"},{"created":"2021-05-07T12:46:30.723191+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.89","user_name":"Seb Lunke","item_type":"entity","text":"Publications for gene: CLCN4 were set to ","entity_name":"CLCN4","entity_type":"gene"},{"created":"2021-05-07T12:46:17.247830+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.88","user_name":"Seb Lunke","item_type":"entity","text":"Mode of inheritance for gene: CLCN4 was changed from X-LINKED: hemizygous mutation in males, biallelic mutations in females to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"CLCN4","entity_type":"gene"},{"created":"2021-05-07T12:45:04.410754+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.87","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: NEXMIF as ready","entity_name":"NEXMIF","entity_type":"gene"},{"created":"2021-05-07T12:45:04.395542+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.87","user_name":"Seb Lunke","item_type":"entity","text":"Gene: nexmif has been classified as Green List (High Evidence).","entity_name":"NEXMIF","entity_type":"gene"},{"created":"2021-05-07T12:44:57.929448+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.87","user_name":"Seb Lunke","item_type":"entity","text":"Phenotypes for gene: NEXMIF were changed from Mental retardation, X-linked 98, 300912 (3) to Mental retardation, X-linked 98, MIM #300912","entity_name":"NEXMIF","entity_type":"gene"},{"created":"2021-05-07T12:44:42.703946+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.86","user_name":"Seb Lunke","item_type":"entity","text":"Mode of inheritance for gene: NEXMIF was changed from X-LINKED: hemizygous mutation in males, biallelic mutations in females to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"NEXMIF","entity_type":"gene"},{"created":"2021-05-07T12:44:17.913229+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.85","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: NHS as ready","entity_name":"NHS","entity_type":"gene"},{"created":"2021-05-07T12:44:17.902578+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.85","user_name":"Seb Lunke","item_type":"entity","text":"Gene: nhs has been classified as Green List (High Evidence).","entity_name":"NHS","entity_type":"gene"},{"created":"2021-05-07T12:44:13.353195+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.85","user_name":"Seb Lunke","item_type":"entity","text":"Mode of inheritance for gene: NHS was changed from X-LINKED: hemizygous mutation in males, biallelic mutations in females to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"NHS","entity_type":"gene"},{"created":"2021-05-07T12:43:46.543713+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.84","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: COL4A5 as ready","entity_name":"COL4A5","entity_type":"gene"},{"created":"2021-05-07T12:43:46.533663+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.84","user_name":"Seb Lunke","item_type":"entity","text":"Gene: col4a5 has been classified as Green List (High Evidence).","entity_name":"COL4A5","entity_type":"gene"},{"created":"2021-05-07T12:43:40.143300+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.84","user_name":"Seb Lunke","item_type":"entity","text":"Mode of inheritance for gene: COL4A5 was changed from X-LINKED: hemizygous mutation in males, biallelic mutations in females to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"COL4A5","entity_type":"gene"},{"created":"2021-05-07T12:43:29.928602+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7534","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: IL21R as ready","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:43:29.919878+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7534","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: il21r has been classified as Green List (High Evidence).","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:43:24.162729+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.195","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: IL21R as ready","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:43:24.143631+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.195","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: il21r has been classified as Green List (High Evidence).","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:43:20.320581+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7534","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: IL21R were changed from  to Immunodeficiency 56, MIM# 615207","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:43:18.999726+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.195","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: IL21R were changed from Immunodeficiency 56, MIM# 615207 to Immunodeficiency 56, MIM# 615207","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:43:02.973554+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.195","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: IL21R were changed from  to Immunodeficiency 56, MIM# 615207","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:42:57.644722+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7533","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: IL21R were set to ","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:42:34.459863+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7532","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: IL21R was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:42:20.721503+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.83","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: NTNG2 as ready","entity_name":"NTNG2","entity_type":"gene"},{"created":"2021-05-07T12:42:20.712560+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.83","user_name":"Seb Lunke","item_type":"entity","text":"Gene: ntng2 has been classified as Amber List (Moderate Evidence).","entity_name":"NTNG2","entity_type":"gene"},{"created":"2021-05-07T12:42:19.687457+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.194","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: IL21R were set to ","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:42:16.895485+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.7531","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: IL21R: Rating: GREEN; Mode of pathogenicity: None; Publications: 33929673; Phenotypes: Immunodeficiency 56, MIM# 615207; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:42:13.161402+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.83","user_name":"Seb Lunke","item_type":"entity","text":"Classified gene: NTNG2 as Amber List (moderate evidence)","entity_name":"NTNG2","entity_type":"gene"},{"created":"2021-05-07T12:42:13.137112+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.83","user_name":"Seb Lunke","item_type":"entity","text":"Added comment: Comment on list classification: Amber for MM due to rarity","entity_name":"NTNG2","entity_type":"gene"},{"created":"2021-05-07T12:42:13.093889+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.83","user_name":"Seb Lunke","item_type":"entity","text":"Gene: ntng2 has been classified as Amber List (Moderate Evidence).","entity_name":"NTNG2","entity_type":"gene"},{"created":"2021-05-07T12:41:35.601048+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.193","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: IL21R was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:41:28.054268+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.82","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: EDA as ready","entity_name":"EDA","entity_type":"gene"},{"created":"2021-05-07T12:41:28.043443+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.82","user_name":"Seb Lunke","item_type":"entity","text":"Gene: eda has been classified as Green List (High Evidence).","entity_name":"EDA","entity_type":"gene"},{"created":"2021-05-07T12:41:20.898964+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.82","user_name":"Seb Lunke","item_type":"entity","text":"Mode of inheritance for gene: EDA was changed from BIALLELIC, autosomal or pseudoautosomal to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"EDA","entity_type":"gene"},{"created":"2021-05-07T12:41:07.755283+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: IL21R: Rating: GREEN; Mode of pathogenicity: None; Publications: 33929673; Phenotypes: Immunodeficiency 56, MIM# 615207; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"IL21R","entity_type":"gene"},{"created":"2021-05-07T12:40:26.759352+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.81","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: MOGS as ready","entity_name":"MOGS","entity_type":"gene"},{"created":"2021-05-07T12:40:26.754737+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.81","user_name":"Seb Lunke","item_type":"entity","text":"Added comment: Comment when marking as ready: Amber due to rarity","entity_name":"MOGS","entity_type":"gene"},{"created":"2021-05-07T12:40:26.732188+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.81","user_name":"Seb Lunke","item_type":"entity","text":"Gene: mogs has been classified as Amber List (Moderate Evidence).","entity_name":"MOGS","entity_type":"gene"},{"created":"2021-05-07T12:40:00.234072+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.81","user_name":"Seb Lunke","item_type":"entity","text":"Deleted their comment","entity_name":"MOGS","entity_type":"gene"},{"created":"2021-05-07T12:39:49.644676+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.81","user_name":"Seb Lunke","item_type":"entity","text":"Classified gene: MOGS as Amber List (moderate evidence)","entity_name":"MOGS","entity_type":"gene"},{"created":"2021-05-07T12:39:49.633456+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.81","user_name":"Seb Lunke","item_type":"entity","text":"Gene: mogs has been classified as Amber List (Moderate Evidence).","entity_name":"MOGS","entity_type":"gene"},{"created":"2021-05-07T12:39:31.666991+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.80","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: MOGS as ready","entity_name":"MOGS","entity_type":"gene"},{"created":"2021-05-07T12:39:31.662044+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.80","user_name":"Seb Lunke","item_type":"entity","text":"Added comment: Comment when marking as ready: Remains red due to rarity","entity_name":"MOGS","entity_type":"gene"},{"created":"2021-05-07T12:39:31.620883+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.80","user_name":"Seb Lunke","item_type":"entity","text":"Gene: mogs has been classified as Red List (Low Evidence).","entity_name":"MOGS","entity_type":"gene"},{"created":"2021-05-07T12:38:59.285007+10:00","panel_name":"Mackenzie's Mission_Reproductive Carrier Screening","panel_id":3139,"panel_version":"0.80","user_name":"Seb Lunke","item_type":"entity","text":"Marked gene: DYNC1I2 as ready","entity_name":"DYNC1I2","entity_type":"gene"}]}